The biologic treatment Greyledge provides is on the forefront of Regenerative Medicine, allowing physicians to offer their patients the most up-to-date therapies in the field.
Greyledge leads the field in both product quality and innovation. We created a system that offers physicians of all specialties a safer, more effective and systemized approach to making biologics a hallmark of their practice.
When physicians partner with us, they commit to more than just a processing facility. We offer data collection and physician-extending technicians committed to improving results and tracking patient reported outcomes.
Dr. David C. Karli recognized early on that understanding the composition of regenerative biologic preparations used in treating his patients would be critical to refining his practice of medicine. He also realized that a “one size fits all” approach to creating therapeutic preparations wouldn’t meet the need for an evidence-based, precision medicine approach.
As a result, he founded Greyledge. Dr. Karli remains responsible for all aspects of our company’s development, including the integration of a strong team of professionals to support Greyledge’s innovative approach to Regenerative Medicine. His insight shapes our mission to this day: our emphasis remains focused on offering physicians and patients a custom cell therapy experience that produces results that reflect the uniqueness of every individual body.
If you’d like to learn more about Dr. Karli and the rest of the committed, passionate Greyledge team, just click below.
We provide advanced, evidence-based therapies designed to support recovery, reduce pain, and improve quality of life across a wide range of medical conditions.
As orthopaedic surgeons, our job is not to operate, it’s to evaluate, educate and help people get better. And if we can find ways to keep our patients on the field or in the gym or completing activities of daily living pain free without going to the Or, then that is a huge win. Platelet rich plasma has been a welcome addition to our armamentarium to help manage tendon, ligament and joint issues as an alternative option to surgery with increasingly positive results.
With that said, the literature is mixed on how well prp works in large part because we are not all using the same prp formulations and preparations. What we have learned is that when you isolate the highest quality Prp (longer spin times, better kits, prep teams etc) that achieves an appropriate dose of platelets, the results speak for themselves. I have an incredible number of patients that have gotten better without surgery that were previously told surgery was the best next step.
And this is where Greyledge comes in. It is the highest quality platelet rich plasma curated by a first rate team, that is then able to deliver not only on the quality of the prp, but also on data about the exact cell counts such as platelets, leukocytes, monocytes which all have a different role in healing and patient reported outcomes to a) tailor the treatment for a specific condition and b) allow us to then study our results so we can identify what is most important about our formulations to drive successful prp treatments in the future.
Linking the diagnosis, to the cell counts, and patient reported outcomes will allow us to prove the efficacy of PRP and scientifically support when our patients may benefit from prp. In turn, we will prove to insurance that it shoulder be a covered treatment modality as an alternative to surgery
3683 S. Miami Ave
(305) 459-3377